#

Books

UPSC PYQs

UPSC Notes

Current Affairs

Others

Home/Current Affairs/Jardiance (Empagliflozin): A News Drug for Chronic Kidney Disease

Jardiance (Empagliflozin): A News Drug for Chronic Kidney Disease

16 Feb 2024

Context: 

Recently, CDSCO has approved Boehringer Ingelheim’s anti-diabetic drug for the treatment of Chronic kidney disease in India.

Central Drugs Standard Control Organization (CDSCO) 

  • It is the National Regulatory Authority (NRA) of India regulates the quality, safety, and efficacy of drugs including vaccines & the medical devices industry.
  • Regulation: Drugs & Cosmetics Act 1940 & New Drugs and Clinical Trials Rules, 2019. 
  • Nodal Ministry: Ministry of Health & Family Welfare. 
  • Headed by: Drugs Controller General of India (DCGI)
  • Headquarters: New Delhi. 

What Is Chronic Kidney Disease (CKD)?

  • It means when kidneys are damaged and can’t filter blood the way they should. 
  • Main Risk factors: Diabetes, High Blood Pressure, Heart disease, and a family history of kidney failure.
  • CKD Burden in India: An estimated 33 million adults live with CKD in India.

About Jardiance Drug Efficacy

  • Reduce the risk of sustained decline in estimated glomerular filtration rate (eGFR) which is done to check how well the kidneys are filtering, and end-stage kidney disease.
  • Reduce Cardiovascular death (Earlier, it was approved only for the treatment of heart failure.)
  • Reduce Hospitalization of Adults with CKD.
Also Read: Casgevy And Lyfgenia: CRISPR-Based Gene Therapies

News Source: Live Mint

Must Read
NCERT Notes For UPSC UPSC Daily Current Affairs
UPSC Blogs UPSC Daily Editorials
Daily Current Affairs Quiz Daily Main Answer Writing
UPSC Mains Previous Year Papers UPSC Test Series 2024

 

Print Friendly, PDF & EmailDOWNLOAD PDF

Follow Us

Need help preparing for UPSC or State PSCs?

Connect with our experts to get free counselling & start preparing

Aiming for UPSC?

Download Our App

# #

Download Our App

# #

Contact Details

Copyright © 2025 PWOnlyIAS
Privacy Policy Terms & Condition

Aiming for UPSC?

Download Our App

# #
      

Follow Us:

Contact Details

Download Our App

# #
Copyright © 2025 PWOnlyIAS
Privacy Policy Terms & Condition
Quick Revise Now !
AVAILABLE FOR DOWNLOAD SOON
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध
Quick Revise Now !
UDAAN PRELIMS WALLAH
Comprehensive coverage with a concise format
Integration of PYQ within the booklet
Designed as per recent trends of Prelims questions
हिंदी में भी उपलब्ध

<div class="new-fform">






    </div>

    Subscribe our Newsletter
    Sign up now for our exclusive newsletter and be the first to know about our latest Initiatives, Quality Content, and much more.
    *Promise! We won't spam you.
    Yes! I want to Subscribe.